FDA approves INREBIC for Myelofibrosis treatment

Press/Media: Press / Media

PeriodAug 19 2019 → Aug 20 2019

Media coverage

3

Media coverage

  • TitleFDA approves INREBIC for Myelofibrosis treatment
    Media name/outletCPhI.cn
    CountryChina
    Date8/20/19
    PersonsRuben Mesa
  • TitleFDA approves INREBIC for Myelofibrosis treatment
    Media name/outletBioSpectrum Asia
    CountrySingapore
    Date8/19/19
    PersonsRuben Mesa
  • TitleFDA approves INREBIC for Myelofibrosis treatment
    Media name/outletBio Spectrum Asia
    CountryIndia
    Date8/19/19
    PersonsRuben Mesa